Detection of IL-13, IL-10, and IL-6 in the leprosy skin lesions of patients during prednisolone treatment for Type 1 (T1R) reactions

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 72, Issue 1, 2004, Pages 27-34

  Atkinson, Sara E ^a   Khanolkar Young, Saroj ^a   Marlowe, Sharon ^a   Jain, Suman ^b   Reddy, Raj Gopal ^b   Suneetha, Sujai ^b   Lockwood, Diana N J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b LEPRA Society   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 6; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; INDIA; INFLAMMATION; LEPROSY; MALE; SKIN BIOPSY;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS; BIOPSY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-6; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; MALE; MIDDLE AGED; PREDNISOLONE; SKIN; TIME FACTORS;

EID: 2942622379     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: 10.1489/1544-581X(2004)072<0027:DOIIAI>2.0.CO;2     Document Type: Article

References (17)

1. BARNES P. J., and KARIN M. Nuclear factor-κB-a pivotal transcription factor in chronic inflammatory diseases. New Eng. J. Med. 10 (1997) 1066-1071.
2. COOPER, A. M., ADAMS, L. B., DALTON, D. K., APPELBERG, R., and EHLERS, S. IFN-gamma and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol. 10 (2002) 221-226.
3. GAYO, A., MOZO, L., SUAREZ, A., TUNON, A., LAHOZ, C., and GUTIERREZ, C. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse. J. Neuroimmunol. 85 (1998) 122-130.
4. GOPPELT-STRUEBE, M. Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochem. Pharmacol. 15 (1997) 1389-1395.
5. HODGE, S., HODGE, G., FLOWER, R., and HAN, P. Methyl-prednisolone up-regulates monocyte interleukin-10 production in stimulated whole blood. Scand. J. Immunol. 49 (1999) 548-553.
6. KHANOLKAR-YOUNG, S., RAYMENT, N., BRICKNELL, P. M., KATZ, D. R., VINAYAKUMAR, S., COLSTON, M. J., and LOCKWOOD, D. N. Tumor necrosis factor-alpha (TNF-α) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin. Exp. Immunol. 99 (1995) 196-202.
7. LAAL, S., MISHRA, R. S., and NATH, I. Type 1 reactions in leprosy-heterogeneity in T-cell functions related to the background leprosy type. Int. J. Lepr. Other Mycobact. Dis. 55 (1987) 481-493.
8. LITTLE, D., KHANOLKAR-YOUNG, S., COULTHART, A., SUNEETHA, S., and LOCKWOOD, D. N. Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy Type 1 (reversal) reactions before and during prednisolone treatment. Infect. Immun. 69 (2001) 3413-3417.
9. LOCKWOOD, D. N., VINAYAKUMAR, S., STANLEY, J. N., MCADAM, K. P., and COLSTON, M. J. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India. Int. J. Lepr. Other Mycobact. Dis. 61 (1993) 8-15.
10. MARCHANT, A., AMRAOUI, Z., GUEYDAN, C., BRUYNS, C., LE MOINE, O., VANDENABEELE, P., FIERS, W., BUURMAN, W. A., and GOLDMAN, M. Methylprednisolone differentially regulates IL-10 and tumour necrosis factor (TNF) production during murine endotoxaemia. Clin. Exp. Immunol. 106 (1996) 91-96.
11. MORAES, M. O., SARNO, E. N., ALMEIDA, A. S., SARAIVA, B. C., NERY, J. A., MARTINS, R. C., and SAMPAIO, E. P. Cytokine mRNA expression in leprosy: a possible role for interferon-gamma and interleukin-12 in reactions (RR and ENL). Scand. J. Immunol. 50 (1999) 541-549.
12. MORAES, M. O., SARNO, E. N., TELES, R. M., ALMEIDA, A. S., SARAIVA, B. C., NERY, J. A., and SAMPAIO, E. P. Anti-inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients. J. Invest. Dermatol. 115 (2000) 935-941.
13. MOUBASHER, A. D., KAMEL, N. A., ZEDAN, H., and RAHEEM, D. D. Cytokines in leprosy, I. Serum cytokine profile in leprosy. Int. J. Dermatol. 37 (1998) 733-740.
14. RICHARDS, D. F., FERNANDEZ, M., CAULFIELD, J., and HAWRYLOWlCZ, C. M. Glucocorticoids drive human CD8(+) T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur. J. Immunol. 30 (2000) 2344-2354.
15. RIDLEY, D. S., and JOPLING, W. H. Classification of leprosy according to immunity. A five group system. Int. J. Lepr. 34 (1966) 255-273.
16. VERVOORDELDONK, M. J., and TAK, P. P. Cytokines in rheumatoid arthritis. Curr. Rheumatol. Rep. 4 (2002) 208-217.
17. YAMAMURA, M., UYEMURA, K., DEANS, R. J., WEINBERG, K., REA, T. H., BLOOM, B. R., and MODLIN, R. L. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254 (1991) 277-279.